Biogen Inc
NASDAQ: BIIB
$199.36
-$2.08 (-1.0%)
Closing Price on September 20, 2024
BIIB Articles
Today’s version of the BioHealth Business Daily has many stocks moving on news, but oddly many of the real news stocks are hardly moving and were eliminated from today’s report. Today’s...
Published:
Last Updated:
Updated thoughout the day. Carl Icahn will push for the sale of Biogen (BIIB) (Bloomberg) Buffett’s Berkshire Hathaway (BRK.B) may be more liquor distributors after picked up Empire (Bloomberg)...
Published:
Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend. We are focusing solely on the biotech,...
Published:
Last Updated:
These are this Friday’s top analyst upgrades, downgrades, and initiations seen from Wall Street morning research calls: Abbott Laboratories (NYSE: ABT) Cut to Sell at Citigroup. Aeropostale (NYSE:...
Published:
Last Updated:
These are this Tuesday morning’s top analyst upgrades, downgrades, and initiations seen in early Wall Street research notes: Biogen Idec (NASDAQ: BIIB) Started as Buy at Soleil. Comerica (NYSE:...
Published:
Last Updated:
We have compiled several options chains we are watching today now that the DEC-2009 PUTS/CALLS have expired on Friday. Much of this likely options roll-outs continuing, but we are seeing some...
Published:
Last Updated:
These are this Monday’s top ten analyst upgrades, downgrades, and initiations seen from Wall Street research firms: Biogen Idec (NASDAQ: BIIB) Raised to Buy at Jefferies. Incyte Corporation...
Published:
Last Updated:
Facet Biotech Corporation (FACT) confirms that it is in receipt of Biogen Idec Inc.’s (BIIB) letter dated September 4, 2009 offering $14.50 per share for all of the outstanding shares of Facet....
Published:
These are the top ten analyst research initiations, upgrades, and downgrades we have seen from top Wall Street firms early this Wednesday morning: Biogen-Idec (BIIB) Started as Underperform at...
Published:
It usually takes an event or a series of events for biotech stocks to ever look cheap compared to the overall market or even to sub-sectors within health care. They generally trade at higher...
Published:
Last Updated:
Reuters: A college education no longer means easy employment in China. Reuters: Fannie Mae (FNM) lost $14.8 billion. Reuters: The auto “clunkers” legislation passed the Senate....
Published:
Last Updated:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec Inc....
Published:
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals...
Published:
Reuters: Cybercrime is spreading fast on Facebook. Reuters: GM will seek to sell most of its assets to a new company. Reuters: Madoff got 150 years in prison. Reuters: AIG (AIG)...
Published:
Last Updated: